reduced glutathione solution preparation Complex ProductInformation

A quantitative analysis of oligodendrocytes in multiple sclerosis lesions

The information presented summarizes preclinical research and should not be construed as medical advice

Cannabidiol (CBD) While Rimonabant was recalled as a pharmaceutical, worldwide in 2008, due to an unexpected increase in depressive symptoms and other side-effects in the larger population, interest in modulation of the cannabinoid system as a potential pharmacological target was only just beginning

TLK286 clinical effects were investigated in the last decade in phase II and phase III trials for the treatment of drug-resistant ovarian cancer 112,113